Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)
NCT ID: NCT00163319
Last Updated: 2016-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
500 participants
INTERVENTIONAL
2004-11-30
2005-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ciclesonide
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of bronchial asthma for at least 6 months
* Pre-treatment with CFC-beclomethasone dipropionate (CFC-BDP) ≥ 1000 mcg/day or equivalent and a long-acting beta agonist (LABA) either in free or fixed combination
* FEV1 ≥ 80% of predicted
Exclusion Criteria
* COPD
* Smoking with ≥10 pack-years
* Pregnancy
* Intention to become pregnant during the course of the study
* Breast feeding
* Lack of safe contraception
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca AstraZeneca
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Altana Pharma/Nycomed
Napoli, , Italy
Altana Pharma/Nycomed
Pavia, , Italy
Altana Pharma/Nycomed
Pirri-Cagliari, , Italy
Altana Pharma/Nycomed
Pordenone, , Italy
Altana Pharma/Nycomed
Roma, , Italy
Altana Pharma/Nycomed
Verona, , Italy
Altana Pharma/Nycomed
Almere Stad, , Netherlands
Altana Pharma/Nycomed
Milazzo (ME), , Italy
Altana Pharma/Nycomed
Brussels, , Belgium
Altana Pharma/Nycomed
Brussels, , Belgium
Altana Pharma/Nycomed
Brussels, , Belgium
Altana Pharma/Nycomed
Halen, , Belgium
Altana Pharma/Nycomed
Jette, , Belgium
Altana Pharma/Nycomed
Maison-Saint-Gérard, , Belgium
Altana Pharma/Nycomed
Namur, , Belgium
Altana Pharma/Nycomed
Ostend, , Belgium
Altana Pharma/Nycomed
Turnhout, , Belgium
Altana Pharma/Nycomed
Veurne, , Belgium
Altana Pharma/Nycomed
Aix-en-Provence, , France
Altana Pharma/Nycomed
Béziers, , France
Altana Pharma/Nycomed
Chauny, , France
Altana Pharma/Nycomed
Grasse, , France
Altana Pharma/Nycomed
La Rochelle, , France
Altana Pharma/Nycomed
Marseille, , France
Altana Pharma/Nycomed
Martigues, , France
Altana Pharma/Nycomed
Metz, , France
Altana Pharma/Nycomed
Montfermeil, , France
Altana Pharma/Nycomed
Montpellier, , France
Altana Pharma/Nycomed
Nice, , France
Altana Pharma/Nycomed
Nîmes, , France
Altana Pharma/Nycomed
Paris, , France
Altana Pharma/Nycomed
Perpignan, , France
Altana Pharma/Nycomed
Vieux-Condé, , France
Altana Pharma/Nycomed
Ancona, , Italy
Altana Pharma/Nycomed
Brescia, , Italy
Altana Pharma/Nycomed
Chieti, , Italy
Altana Pharma/Nycomed
Florence, , Italy
Altana Pharma/Nycomed
Livorno, , Italy
Altana Pharma/Nycomed
Milan, , Italy
Altana Pharma/Nycomed
Milan, , Italy
Altana Pharma/Nycomed
Haarlem, , Netherlands
Altana Pharma/Nycomed
Harderwijk, , Netherlands
Altana Pharma/Nycomed
Heerlen, , Netherlands
Altana Pharma/Nycomed
Helmond, , Netherlands
Altana Pharma/Nycomed
Schiedam, , Netherlands
Altana Pharma/Nycomed
Utrecht, , Netherlands
Altana Pharma/Nycomed
Veldhoven, , Netherlands
Altana Pharma/Nycomed
Almería, , Spain
Altana Pharma/Nycomed
Barcelona, , Spain
Altana Pharma/Nycomed
Córdoba, , Spain
Altana Pharma/Nycomed
Elche, , Spain
Altana Pharma/Nycomed
Guadalajara, , Spain
Altana Pharma/Nycomed
Madrid, , Spain
Altana Pharma/Nycomed
Madrid, , Spain
Altana Pharma/Nycomed
Madrid, , Spain
Altana Pharma/Nycomed
Madrid, , Spain
Altana Pharma/Nycomed
Requena, , Spain
Altana Pharma/Nycomed
San Sebastián, , Spain
Altana Pharma/Nycomed
Valencia, , Spain
Altana Pharma/Nycomed
Valencia, , Spain
Altana Pharma/Nycomed
Basel, , Switzerland
Altana Pharma/Nycomed
Bellinzona, , Switzerland
Altana Pharma/Nycomed
Bern, , Switzerland
Altana Pharma/Nycomed
Bruderholz, , Switzerland
Altana Pharma/Nycomed
La Chauxe-de-Fonds, , Switzerland
Altana Pharma/Nycomed
Lugano, , Switzerland
Altana Pharma/Nycomed
Münchenstein, , Switzerland
Altana Pharma/Nycomed
Münsingen, , Switzerland
Altana Pharma/Nycomed
Münsterlingen, , Switzerland
Altana Pharma/Nycomed
Zurich, , Switzerland
Altana Pharma/Nycomed
Zurich, , Switzerland
Altana Pharma/Nycomed
Zurich, , Switzerland
Altana Pharma/Nycomed
Belfast, , United Kingdom
Altana Pharma/Nycomed
Belfast, Irland, , United Kingdom
Altana Pharma/Nycomed
Bradford on Avon, Wiltshire, , United Kingdom
Altana Pharma/Nycomed
Chesterfield Derbyshire, , United Kingdom
Altana Pharma/Nycomed
Chippenham, Wiltshire, , United Kingdom
Altana Pharma/Nycomed
Co. Antrim, , United Kingdom
Altana Pharma/Nycomed
Downpatrick, Northern Ireland, , United Kingdom
Altana Pharma/Nycomed
Dronfield, , United Kingdom
Altana Pharma/Nycomed
Glengormley, , United Kingdom
Altana Pharma/Nycomed
Glengormley Newtownabbey, , United Kingdom
Altana Pharma/Nycomed
Hastings, , United Kingdom
Altana Pharma/Nycomed
Maidenhead, Berks, , United Kingdom
Altana Pharma/Nycomed
Nottingham, , United Kingdom
Altana Pharma/Nycomed
Nottingham, , United Kingdom
Altana Pharma/Nycomed
Solihull, , United Kingdom
Altana Pharma/Nycomed
Warminster Wiltshire, , United Kingdom
Altana Pharma/Nycomed
Watford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
BY9010-IT-101-RDS-2006-09-21.pdf
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BY9010/IT-101
Identifier Type: -
Identifier Source: org_study_id